{"_buckets": {"deposit": "ae029cea-b01d-4067-a802-23510147fd3a"}, "_deposit": {"id": "20847", "owners": [], "pid": {"revision_id": 0, "type": "depid", "value": "20847"}, "status": "published"}, "_oai": {"id": "oai:soar-ir.repo.nii.ac.jp:00020847", "sets": ["461:462"]}, "author_link": ["108337", "108338", "108339", "108340", "108341", "108342", "108343", "108344", "108345", "108346", "108347", "108348", "108349", "108350"], "item_1628147817048": {"attribute_name": "\u51fa\u7248\u30bf\u30a4\u30d7", "attribute_value_mlt": [{"subitem_version_resource": "http://purl.org/coar/version/c_970fb48d4fbd8a85", "subitem_version_type": "VoR"}]}, "item_6_biblio_info_6": {"attribute_name": "\u66f8\u8a8c\u60c5\u5831", "attribute_value_mlt": [{"bibliographicIssueDates": {"bibliographicIssueDate": "2018-05-25", "bibliographicIssueDateType": "Issued"}, "bibliographicPageStart": "8159", "bibliographicVolumeNumber": "8", "bibliographic_titles": [{"bibliographic_title": "SCIENTIFIC REPORTS"}]}]}, "item_6_description_20": {"attribute_name": "\u6284\u9332", "attribute_value_mlt": [{"subitem_description": "Autotaxin (ATX) is a secreted enzyme metabolized by liver sinusoidal endothelial cells that has been associated with liver fibrosis. We evaluated serum ATX values in 128 treatment-naive, histologically assessed primary biliary cholangitis (PBC) patients and 80 healthy controls for comparisons of clinical parameters in a case-control study. The median ATX concentrations in controls and PBC patients of Nakanuma\u0027s stage I, II, III, and IV were 0.70, 0.80, 0.87, 1.03, and 1.70 mg/L, respectively, which increased significantly with disease stage (r = 0.53, P \u003c 0.0001) as confirmed by Scheuer\u0027s classification (r = 0.43, P \u003c 0.0001). ATX correlated with Wisteria floribunda agglutinin-positive Mac-2 binding protein (M2BPGi) (r = 0.51, P \u003c 0.0001) and fibrosis index based on four factors (FIB-4) index (r = 0.51, P \u003c 0.0001). While ALP and M2BPGi levels had decreased significantly (both P \u003c 0.001) by 12 months of ursodeoxycholic acid treatment, ATX had not (0.95 to 0.96 mg/L) (P = 0.07). We observed in a longitudinal study that ATX increased significantly (P \u003c 0.00001) over 18 years in an independent group of 29 patients. Patients succumbing to disease-related death showed a significantly higher ATX increase rate (0.05 mg/L/year) than did survivors (0.02 mg/L/year) (P \u003c 0.01). ATX therefore appears useful for assessing disease stage and prognosis in PBC.", "subitem_description_type": "Abstract"}]}, "item_6_description_30": {"attribute_name": "\u8cc7\u6e90\u30bf\u30a4\u30d7\uff08\u30b3\u30f3\u30c6\u30f3\u30c4\u306e\u7a2e\u985e\uff09", "attribute_value_mlt": [{"subitem_description": "Article", "subitem_description_type": "Other"}]}, "item_6_description_5": {"attribute_name": "\u5f15\u7528", "attribute_value_mlt": [{"subitem_description": "SCIENTIFIC REPORTS.8:8159(2018)", "subitem_description_type": "Other"}]}, "item_6_link_3": {"attribute_name": "\u4fe1\u5dde\u5927\u5b66\u7814\u7a76\u8005\u7dcf\u89a7\u3078\u306e\u30ea\u30f3\u30af", "attribute_value_mlt": [{"subitem_link_text": "Joshita, Satoru", "subitem_link_url": "http://soar-rd.shinshu-u.ac.jp/profile/ja.PeLNbVym.html"}, {"subitem_link_text": "Umemura, Takeji", "subitem_link_url": "http://soar-rd.shinshu-u.ac.jp/profile/ja.ymSpgpkh.html"}, {"subitem_link_text": "Yamazaki, Tomoo", "subitem_link_url": "http://soar-rd.shinshu-u.ac.jp/profile/ja.yULaPUym.html"}, {"subitem_link_text": "Kimura, Takefumi", "subitem_link_url": "http://soar-rd.shinshu-u.ac.jp/profile/ja.uNymWUkh.html"}, {"subitem_link_text": "Matsumoto, Akihiro", "subitem_link_url": "http://soar-rd.shinshu-u.ac.jp/profile/ja.jhSCPUym.html"}, {"subitem_link_text": "Ota, Masao", "subitem_link_url": "http://soar-rd.shinshu-u.ac.jp/profile/ja.ZefVOFkh.html"}, {"subitem_link_text": "Tanaka, Eiji", "subitem_link_url": "http://soar-rd.shinshu-u.ac.jp/profile/ja.HFDCHekh.html"}]}, "item_6_link_67": {"attribute_name": "WoS", "attribute_value_mlt": [{"subitem_link_text": "Web of Science", "subitem_link_url": "http://gateway.isiknowledge.com/gateway/Gateway.cgi?\u0026GWVersion=2\u0026SrcAuth=ShinshuUniv\u0026SrcApp=ShinshuUniv\u0026DestLinkType=FullRecord\u0026DestApp=WOS\u0026KeyUT=000433061300041"}]}, "item_6_publisher_4": {"attribute_name": "\u51fa\u7248\u8005", "attribute_value_mlt": [{"subitem_publisher": "NATURE PUBLISHING GROUP"}]}, "item_6_relation_47": {"attribute_name": "PubMed", "attribute_value_mlt": [{"subitem_relation_name": [{"subitem_relation_name_text": "29802350"}], "subitem_relation_type_id": {"subitem_relation_type_id_text": "https://www.ncbi.nlm.nih.gov/pubmed/29802350", "subitem_relation_type_select": "PMID"}}]}, "item_6_relation_48": {"attribute_name": "DOI", "attribute_value_mlt": [{"subitem_relation_name": [{"subitem_relation_name_text": "10.1038/s41598-018-26531-0"}], "subitem_relation_type_id": {"subitem_relation_type_id_text": "https://doi.org/10.1038/s41598-018-26531-0", "subitem_relation_type_select": "DOI"}}]}, "item_6_rights_62": {"attribute_name": "\u6a29\u5229", "attribute_value_mlt": [{"subitem_rights": "\u00a9 The Author(s) 2018. This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article\u2019s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article\u2019s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/."}]}, "item_6_select_64": {"attribute_name": "\u8457\u8005\u7248\u30d5\u30e9\u30b0", "attribute_value_mlt": [{"subitem_select_item": "publisher"}]}, "item_6_source_id_35": {"attribute_name": "ISSN", "attribute_value_mlt": [{"subitem_source_identifier": "2045-2322", "subitem_source_identifier_type": "EISSN"}]}, "item_6_source_id_39": {"attribute_name": "NII ISSN", "attribute_value_mlt": [{"subitem_source_identifier": "2045-2322", "subitem_source_identifier_type": "EISSN"}]}, "item_6_text_69": {"attribute_name": "wosonly authkey", "attribute_value_mlt": [{"subitem_text_value": "SIMPLE NONINVASIVE INDEX; GENOME-WIDE ASSOCIATION; CHRONIC HEPATITIS-C; LYSOPHOSPHATIDIC ACID; LIVER FIBROSIS; URSODEOXYCHOLIC ACID; JAPANESE PATIENTS; BIOCHEMICAL RESPONSE; SUSCEPTIBILITY LOCI; LYSOPHOSPHOLIPASE-D"}]}, "item_6_text_70": {"attribute_name": "wosonly keywords", "attribute_value_mlt": [{"subitem_text_value": "Autotaxin (ATX) is a secreted enzyme metabolized by liver sinusoidal endothelial cells that has been associated with liver fibrosis. We evaluated serum ATX values in 128 treatment-naive, histologically assessed primary biliary cholangitis (PBC) patients and 80 healthy controls for comparisons of clinical parameters in a case-control study. The median ATX concentrations in controls and PBC patients of Nakanuma\u0027s stage I, II, III, and IV were 0.70, 0.80, 0.87, 1.03, and 1.70 mg/L, respectively, which increased significantly with disease stage (r = 0.53, P \u003c 0.0001) as confirmed by Scheuer\u0027s classification (r = 0.43, P \u003c 0.0001). ATX correlated with Wisteria floribunda agglutinin-positive Mac-2 binding protein (M2BPGi) (r = 0.51, P \u003c 0.0001) and fibrosis index based on four factors (FIB-4) index (r = 0.51, P \u003c 0.0001). While ALP and M2BPGi levels had decreased significantly (both P \u003c 0.001) by 12 months of ursodeoxycholic acid treatment, ATX had not (0.95 to 0.96 mg/L) (P = 0.07). We observed in a longitudinal study that ATX increased significantly (P \u003c 0.00001) over 18 years in an independent group of 29 patients. Patients succumbing to disease-related death showed a significantly higher ATX increase rate (0.05 mg/L/year) than did survivors (0.02 mg/L/year) (P \u003c 0.01). ATX therefore appears useful for assessing disease stage and prognosis in PBC."}]}, "item_creator": {"attribute_name": "\u8457\u8005", "attribute_type": "creator", "attribute_value_mlt": [{"creatorNames": [{"creatorName": "Joshita, Satoru", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "108337", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Umemura, Takeji", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "108338", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Usami, Yoko", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "108339", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Yamashita, Yuki", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "108340", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Norman, Gary L.", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "108341", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Sugiura, Ayumi", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "108342", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Yamazaki, Tomoo", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "108343", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Fujimori, Naoyuki", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "108344", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Kimura, Takefumi", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "108345", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Matsumoto, Akihiro", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "108346", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Igarashi, Koji", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "108347", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Yoshizawa, Kaname", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "108348", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Ota, Masao", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "108349", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Tanaka, Eiji", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "108350", "nameIdentifierScheme": "WEKO"}]}]}, "item_files": {"attribute_name": "\u30d5\u30a1\u30a4\u30eb\u60c5\u5831", "attribute_type": "file", "attribute_value_mlt": [{"accessrole": "open_date", "date": [{"dateType": "Available", "dateValue": "2019-09-09"}], "displaytype": "detail", "download_preview_message": "", "file_order": 0, "filename": "16K21069_01.pdf", "filesize": [{"value": "2.1 MB"}], "format": "application/pdf", "future_date_message": "", "is_thumbnail": false, "licensefree": "\u00a9 The Author(s) 2018. This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article\u2019s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article\u2019s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.", "licensetype": "license_note", "mimetype": "application/pdf", "size": 2100000.0, "url": {"label": "16K21069_01.pdf", "url": "https://soar-ir.repo.nii.ac.jp/record/20847/files/16K21069_01.pdf"}, "version_id": "d2891738-0f4e-4392-92e0-37846ae88e5e"}]}, "item_language": {"attribute_name": "\u8a00\u8a9e", "attribute_value_mlt": [{"subitem_language": "eng"}]}, "item_resource_type": {"attribute_name": "\u8cc7\u6e90\u30bf\u30a4\u30d7", "attribute_value_mlt": [{"resourcetype": "journal article", "resourceuri": "http://purl.org/coar/resource_type/c_6501"}]}, "item_title": "Serum Autotaxin Is a Useful Disease Progression Marker in Patients with Primary Biliary Cholangitis", "item_titles": {"attribute_name": "\u30bf\u30a4\u30c8\u30eb", "attribute_value_mlt": [{"subitem_title": "Serum Autotaxin Is a Useful Disease Progression Marker in Patients with Primary Biliary Cholangitis", "subitem_title_language": "en"}]}, "item_type_id": "6", "owner": "1", "path": ["461/462"], "permalink_uri": "http://hdl.handle.net/10091/00021604", "pubdate": {"attribute_name": "PubDate", "attribute_value": "2019-09-09"}, "publish_date": "2019-09-09", "publish_status": "0", "recid": "20847", "relation": {}, "relation_version_is_last": true, "title": ["Serum Autotaxin Is a Useful Disease Progression Marker in Patients with Primary Biliary Cholangitis"], "weko_shared_id": -1}